NCT03612791 2026-04-03ATEZOLACCGustave Roussy, Cancer Campus, Grand ParisPhase 2 Completed189 enrolled
NCT04303858 2026-04-01A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid TumorsHoffmann-La RochePhase 1 Completed189 enrolled
NCT05359861 2026-03-18Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular CarcinomaCoherus Oncology, Inc.Phase 2 Completed30 enrolled